October 8, 2025 - 21:00

The Ellison name is taking shape to be the future of movies, streaming, TV shows, and more. As Larry Ellison, Oracle cofounder, and his son expand their empire from databases to Hollywood, the landscape of entertainment could be on the brink of a significant transformation. At 81 years old, Ellison is not just a tech billionaire but is now positioning himself as a formidable player in the media space.
With potential ownership of major networks such as CBS, Paramount, CNN, and even TikTok on the horizon, the Ellison family’s influence could reshape how content is created and consumed. This shift could bring innovative approaches to storytelling and distribution, leveraging the technological expertise that has defined Ellison’s career. As traditional media faces challenges from digital platforms, the Ellisons are poised to bring a fresh perspective that blends technology with entertainment.
As they venture further into this new domain, the impact of their endeavors will be closely watched by industry insiders and audiences alike. The future of media may very well be in the hands of the Ellison family.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...